Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases

NCT01472263 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

HTLV-1
Tropical Spastic Paraparesis
Immune System Diseases
Physical Disability
Pentoxifylline

Interventions

DRUG: Pentoxifylline
DRUG: Placebo

Sponsor

Hospital Universitário Professor Edgard Santos